Benjamin F. Edwards & Company Inc. Grows Stock Holdings in Zoetis Inc. (NYSE:ZTS)

Benjamin F. Edwards & Company Inc. grew its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 3.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 146,626 shares of the company’s stock after buying an additional 5,038 shares during the quarter. Benjamin F. Edwards & Company Inc.’s holdings in Zoetis were worth $25,419,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Price T Rowe Associates Inc. MD lifted its position in shares of Zoetis by 31.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,716,681 shares of the company’s stock worth $2,707,262,000 after purchasing an additional 3,244,074 shares in the last quarter. Sarasin & Partners LLP lifted its position in shares of Zoetis by 546.3% during the second quarter. Sarasin & Partners LLP now owns 2,253,590 shares of the company’s stock worth $390,682,000 after purchasing an additional 1,904,899 shares in the last quarter. Swedbank AB acquired a new position in shares of Zoetis during the first quarter worth $210,815,000. Public Employees Retirement Association of Colorado acquired a new position in shares of Zoetis during the fourth quarter worth $242,757,000. Finally, CIBC Private Wealth Group LLC lifted its position in shares of Zoetis by 122.6% during the fourth quarter. CIBC Private Wealth Group LLC now owns 1,448,665 shares of the company’s stock worth $285,923,000 after purchasing an additional 797,884 shares in the last quarter. 92.80% of the stock is currently owned by hedge funds and other institutional investors.

Zoetis Stock Performance

Shares of ZTS opened at $193.24 on Friday. The firm has a 50-day moving average price of $184.42 and a 200 day moving average price of $174.44. The firm has a market capitalization of $88.17 billion, a PE ratio of 37.23, a P/E/G ratio of 2.98 and a beta of 0.88. The company has a quick ratio of 2.09, a current ratio of 3.45 and a debt-to-equity ratio of 1.32. Zoetis Inc. has a 52-week low of $144.80 and a 52-week high of $201.92.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $1.56 EPS for the quarter, beating analysts’ consensus estimates of $1.49 by $0.07. Zoetis had a net margin of 26.29% and a return on equity of 50.67%. The company had revenue of $2.36 billion during the quarter, compared to analyst estimates of $2.31 billion. During the same period in the prior year, the firm earned $1.41 earnings per share. The business’s quarterly revenue was up 8.3% on a year-over-year basis. On average, sell-side analysts anticipate that Zoetis Inc. will post 5.84 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have recently commented on ZTS shares. Stifel Nicolaus boosted their target price on shares of Zoetis from $200.00 to $210.00 and gave the stock a “buy” rating in a research report on Wednesday. Argus raised shares of Zoetis to a “strong-buy” rating in a report on Friday, August 9th. Piper Sandler upped their price target on shares of Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a report on Wednesday, August 14th. Finally, BTIG Research upped their price target on shares of Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a report on Monday, August 12th. Nine analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $220.38.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.